PRKACA 抗体 (N-Term)
(3 references)-
- 抗原 See all PRKACA 抗体
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
抗原表位
- N-Term
-
适用
- 人, 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PRKACA antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 原理
- Rabbit polyclonal antibody raised against synthetic peptide of PRKACA.
- 交叉反应
- 人, 小鼠
- 免疫原
- A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human PRKACA.
-
anti-Protein Kinase A, alpha (PRKACA) (Center) antibody
PRKACA 适用: 人, 小鼠 WB, IHC (p), IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Protein Kinase A, alpha (PRKACA) (AA 233-351), (Catalytic Subunit alpha) antibodyPRKACA 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Protein Kinase A, alpha (PRKACA) (Internal Region) antibodyPRKACA 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Protein Kinase A, alpha (PRKACA) (pThr197) antibodyPRKACA 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Protein Kinase A, alpha (PRKACA) (pThr197) antibodyPRKACA 适用: 人, 小鼠, 大鼠 WB, IHC (p), IF 宿主: 兔 Polyclonal unconjugated
anti-Protein Kinase A, alpha (PRKACA) (AA 1-120) antibodyPRKACA 适用: 人 WB, ELISA, PLA 宿主: 小鼠 Monoclonal 1D7 unconjugated
anti-Protein Kinase A, alpha (PRKACA) (AA 1-120) antibodyPRKACA 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 7H3A4 unconjugated
anti-Protein Kinase A, alpha (PRKACA) (AA 1-120) antibodyPRKACA 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Protein Kinase A, alpha (PRKACA) antibodyPRKACA 适用: 人 WB, DB 宿主: 小鼠 Monoclonal 6D2-1 unconjugated
anti-Protein Kinase A, alpha (PRKACA) (pSer339) antibodyPRKACA 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
ELISA (1:1000)
Western Blot (1:100-500)
Immunohistochemistry (1:50-100)
The optimal working dilution should be determined by the end user. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- In PBS (0.09 % sodium azide)
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets." in: Thrombosis and haemostasis, Vol. 89, Issue 2, pp. 310-7, (2003) (PubMed).
: "Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein." in: The Journal of biological chemistry, Vol. 278, Issue 37, pp. 35211-9, (2003) (PubMed).
: "Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation." in: The Journal of biological chemistry, Vol. 278, Issue 47, pp. 46718-26, (2003) (PubMed).
-
: "Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets." in: Thrombosis and haemostasis, Vol. 89, Issue 2, pp. 310-7, (2003) (PubMed).
-
- 抗原
- PRKACA (Protein Kinase A, alpha (PRKACA))
- 别名
- PRKACA (PRKACA 产品)
- 别名
- PKACA antibody, Calpha antibody, Cs-PKA antibody, PKCA1 antibody, PKA antibody, PKCD antibody, Pkaca antibody, zgc:158799 antibody, protein kinase cAMP-activated catalytic subunit alpha antibody, protein kinase, cAMP dependent, catalytic, alpha antibody, cAMP-dependent protein kinase catalytic subunit antibody, protein kinase, cAMP-dependent, catalytic, alpha, genome duplicate a antibody, PRKACA antibody, Prkaca antibody, kin-1 antibody, prkacaa antibody
- 基因ID
- 5566
- 途径
- NF-kappaB Signaling, Hedgehog Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-
